Cargando…
Acute panuveitis after COVID-19 mRNA booster vaccination following cataract surgery
PURPOSE: To report a case of presumed COVID-19 Pfizer third dose (booster) vaccination leading to severe panuveitis mimicking acute endophthalmitis in the early postoperative period following routine cataract extraction and intraocular lens implantation. OBSERVATIONS: A 68-year-old female with mild...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557133/ https://www.ncbi.nlm.nih.gov/pubmed/36267387 http://dx.doi.org/10.1016/j.ajoc.2022.101726 |
_version_ | 1784807235665264640 |
---|---|
author | Kung, Timothy-Paul H. Zhang, Charles Sieminski, Sandra F. |
author_facet | Kung, Timothy-Paul H. Zhang, Charles Sieminski, Sandra F. |
author_sort | Kung, Timothy-Paul H. |
collection | PubMed |
description | PURPOSE: To report a case of presumed COVID-19 Pfizer third dose (booster) vaccination leading to severe panuveitis mimicking acute endophthalmitis in the early postoperative period following routine cataract extraction and intraocular lens implantation. OBSERVATIONS: A 68-year-old female with mild refractive error who previously received 2 doses of the BNT162b2 vaccine underwent routine cataract extraction and intraocular lens implantation in the right eye. On postoperative day (POD) 2 the patient received her BNT162b2 booster vaccination. On POD 3 the patient's vision was hand motion at face with photophobia. Anterior segment examination was significant for 2+ conjunctival injection, mild stromal edema, 4+ cell and flare with trace hypopyon, and 4+ anterior vitreous cell without any wound leak. Subsequent Gram staining, culture for aerobic and anaerobic bacteria, KOH preparation, and PCR testing for infectious organisms were also obtained, all of which were found to be negative. ESR and CRP values were also negative. The patient was started on intravitreal injections of vancomycin and ceftazidime, as well as oral moxifloxacin, fortified vancomycin and tobramycin drops, prednisolone acetate 1%, and atropine 1%. On POD 5 the patient reported significant improvement of her vision and was found to have 20/80 vision. On POD 12 her vision improved to 20/25, and improved further on POD 19 to 20/20 vision with a completely normal examination. Cultures remained negative throughout the entire course. CONCLUSIONS AND IMPORTANCE: This is the first report to suggest a possible association between the BNT162b2 booster vaccination and development of acute panuveitis in the postoperative period after routine cataract extraction and intraocular lens implantation. This condition may mimic acute bacterial postoperative endophthalmitis and may portend a more favorable prognosis, but the authors believe such cases should nonetheless be treated aggressively as presumed infection. |
format | Online Article Text |
id | pubmed-9557133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95571332022-10-16 Acute panuveitis after COVID-19 mRNA booster vaccination following cataract surgery Kung, Timothy-Paul H. Zhang, Charles Sieminski, Sandra F. Am J Ophthalmol Case Rep Case Report PURPOSE: To report a case of presumed COVID-19 Pfizer third dose (booster) vaccination leading to severe panuveitis mimicking acute endophthalmitis in the early postoperative period following routine cataract extraction and intraocular lens implantation. OBSERVATIONS: A 68-year-old female with mild refractive error who previously received 2 doses of the BNT162b2 vaccine underwent routine cataract extraction and intraocular lens implantation in the right eye. On postoperative day (POD) 2 the patient received her BNT162b2 booster vaccination. On POD 3 the patient's vision was hand motion at face with photophobia. Anterior segment examination was significant for 2+ conjunctival injection, mild stromal edema, 4+ cell and flare with trace hypopyon, and 4+ anterior vitreous cell without any wound leak. Subsequent Gram staining, culture for aerobic and anaerobic bacteria, KOH preparation, and PCR testing for infectious organisms were also obtained, all of which were found to be negative. ESR and CRP values were also negative. The patient was started on intravitreal injections of vancomycin and ceftazidime, as well as oral moxifloxacin, fortified vancomycin and tobramycin drops, prednisolone acetate 1%, and atropine 1%. On POD 5 the patient reported significant improvement of her vision and was found to have 20/80 vision. On POD 12 her vision improved to 20/25, and improved further on POD 19 to 20/20 vision with a completely normal examination. Cultures remained negative throughout the entire course. CONCLUSIONS AND IMPORTANCE: This is the first report to suggest a possible association between the BNT162b2 booster vaccination and development of acute panuveitis in the postoperative period after routine cataract extraction and intraocular lens implantation. This condition may mimic acute bacterial postoperative endophthalmitis and may portend a more favorable prognosis, but the authors believe such cases should nonetheless be treated aggressively as presumed infection. Elsevier 2022-10-13 /pmc/articles/PMC9557133/ /pubmed/36267387 http://dx.doi.org/10.1016/j.ajoc.2022.101726 Text en © 2022 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Kung, Timothy-Paul H. Zhang, Charles Sieminski, Sandra F. Acute panuveitis after COVID-19 mRNA booster vaccination following cataract surgery |
title | Acute panuveitis after COVID-19 mRNA booster vaccination following cataract surgery |
title_full | Acute panuveitis after COVID-19 mRNA booster vaccination following cataract surgery |
title_fullStr | Acute panuveitis after COVID-19 mRNA booster vaccination following cataract surgery |
title_full_unstemmed | Acute panuveitis after COVID-19 mRNA booster vaccination following cataract surgery |
title_short | Acute panuveitis after COVID-19 mRNA booster vaccination following cataract surgery |
title_sort | acute panuveitis after covid-19 mrna booster vaccination following cataract surgery |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557133/ https://www.ncbi.nlm.nih.gov/pubmed/36267387 http://dx.doi.org/10.1016/j.ajoc.2022.101726 |
work_keys_str_mv | AT kungtimothypaulh acutepanuveitisaftercovid19mrnaboostervaccinationfollowingcataractsurgery AT zhangcharles acutepanuveitisaftercovid19mrnaboostervaccinationfollowingcataractsurgery AT sieminskisandraf acutepanuveitisaftercovid19mrnaboostervaccinationfollowingcataractsurgery |